Clincosm LogoSign in Get a demo

acute promyelocytic leukemia

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Brussels, Belgium
    • +30 more
    Aug 9, 2022

    Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

    Recruiting
    • Acute Promyelocytic Leukemia
    • Birmingham, Alabama
    • +4 more
    Jul 12, 2022

    Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

    Recruiting
    • Acute Promyelocytic Leukemia
    • Arsenic Trioxide
    • Alessandria, Italy
    • +27 more
    Dec 31, 2021

    Pregnancy in Acute Promielocitic Leukaemia Patients Treated With

    Recruiting
    • Acute Promyelocytic Leukemia
    • Pregnancy
      • Alessandria, Italy
      • +36 more
      Dec 31, 2021

      Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

      Completed
      Has Results
      • Acute Promyelocytic Leukemia
      • Tretinoin and Arsenic Trioxide
      • Los Angeles, California
      • +11 more
      Nov 2, 2021

      Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

      Recruiting
      • Acute Promyelocytic Leukemia
      • Realgar-Indigo naturalis formula
      • +3 more
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xi'an Jiaotong University
      Aug 31, 2021

      Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

      Active, not recruiting
      • Leukemia
      • +2 more
      • laboratory biomarker analysis
      • San Diego, California
      • +50 more
      Aug 16, 2021

      Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO

      Active, not recruiting
      • Acute Promyelocytic Leukemia
      • QoL questionnaires
      • Ascoli Piceno, Italy
      • +15 more
      Feb 3, 2021

      Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

      Recruiting
      • Acute Promyelocytic Leukemia
      • Oral Arsenic Trioxide Formulation
      • Hong Kong, Hong Kong
        The University of Hong Kong
      Dec 29, 2020

      Acute Promyelocytic Leukemia Trial in Hong Kong (Oral arsenic Trioxide, ATRA and ascorbic acid)

      Recruiting
      • Acute Promyelocytic Leukemia
      • Oral arsenic Trioxide, ATRA and ascorbic acid
      • Hong Kong, N/A = Not Applicable, Hong Kong
        Department of Medicine, the University of Hong Kong, Queen Mary
      Nov 3, 2020

      Acute Promyelocytic Leukemia Trial in Bari, Pavia, Roma (all-trans retinoic acid (ATRA))

      Recruiting
      • Acute Promyelocytic Leukemia
      • all-trans retinoic acid (ATRA)
      • Bari, Italy
      • +2 more
      Oct 12, 2020

      Acute Promyelocytic Leukemia Trial in Shanghai (ATRA+Arsenic, ATRA+Chemo)

      Unknown status
      • Acute Promyelocytic Leukemia
      • Shanghai, China
        Department of Hematology
      Aug 15, 2019

      Acute Promyelocytic Leukemia Trial in Houston (All-Trans Retinoic Acid (ATRA), Arsenic Trioxide (ATO), Idarubicin)

      Completed
      Has Results
      • Acute Promyelocytic Leukemia
      • All-Trans Retinoic Acid (ATRA)
      • +3 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Apr 23, 2019

      Microparticles in Coagulopathy of Acute Promyelocytic Leukemia

      Unknown status
      • Acute Promyelocytic Leukemia
        • Harbin, Heilongjiang, China
          the First Affiliated Hospital of Harbin Medical University
        Apr 22, 2018

        Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,

        Terminated
        • Myelodysplastic Syndrome
        • +9 more
        • Phoenix, Arizona
        • +6 more
        Feb 13, 2018

        Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia Trial in United States (HMA, SGN-CD33A)

        Completed
        • Acute Myelogenous Leukemia
        • +2 more
        • Birmingham, Alabama
        • +13 more
        Jan 3, 2018

        Acute Promyelocytic Leukemia Trial in Roma (ATRA, ATRA + IDA)

        Unknown status
        • Acute Promyelocytic Leukemia
        • Roma, Italy
          Dipartimento di Biotecnologie Cellulari ed Ematologia
        Jan 25, 2017

        Acute Promyelocytic Leukemia Trial in France

        Recruiting
        • Acute Promyelocytic Leukemia
          • Aix en Provence, France
          • +26 more
          Oct 17, 2016

          Acute Promyelocytic Leukemia Trial in Los Angeles (NRX 195183 (retinoid analogue), Arsenic Trioxide)

          Withdrawn
          • Acute Promyelocytic Leukemia
          • NRX 195183 (retinoid analogue)
          • Arsenic Trioxide
          • Los Angeles, California
            USC/Norris Comprehensive Cancer Center
          Oct 24, 2015

          Acute Promyelocytic Leukemia, Relapse Trial in Shanghai (autologous hematopoietic cell transplantation)

          Terminated
          • Acute Promyelocytic Leukemia
          • Relapse
          • autologous hematopoietic cell transplantation
          • Shanghai, China
            Rui Jin Hospital, Shanghai JiaoTong University School of Medicin
          Dec 1, 2014

          Acute Promyelocytic Leukemia Trial in Poland, Spain, Uruguay (ATRA, Idarubicina, Mitoxantrone)

          Completed
          • Acute Promyelocytic Leukemia
          • Lodz, Poland
          • +41 more
          Oct 27, 2014

          Acute Promyelocytic Leukemia Trial in Spain (Arsenic Trioxide, Autologous Transplantation, Allogenic Transplantation)

          Completed
          • Acute Promyelocytic Leukemia
          • Arsenic Trioxide
          • +3 more
          • Oviedo, Asturias, Spain
          • +84 more
          Oct 27, 2014

          Long-Term Quality of Life in Acute Promyelocytic Leukemia

          Completed
          • Acute Promyelocytic Leukemia
          • Health Related Quality of Life (HRQOL) measures
          • Alessandria, Italy
          • +37 more
          Oct 1, 2014